At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,024 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevalence of Rheumatic Heart Disease in Zambian Schoolchildren: an Echocardiographic Screening Study Involving Task-shifting to General Radiographers
In Brief
An observational study for Rheumatic Heart Disease. Completed, enrolled 1,024 participants across 1 site.
Detailed Summary
This study will determine the prevalence of rheumatic heart disease (RHD) in Lusaka, Zambia through school-based screening methodology using ultraportable echocardiography and a recently validated, abridged screening protocol based on World Heart Federation criteria. Children that screen positive for RHD at schools will undergo confirmatory evaluation at University Teaching Hospital (UTH), Lusaka's main referral hospital.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatic Heart Disease
CountriesZambia
CollaboratorsUniversity of Cape Town, Novartis
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
Primary CompletionDec 2015
First PostedJan 2016
TodayJul 2026
First PostedJan 22, 2016
Enrollment StartSep 1, 2015
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.4 years ago